A Simple Endoscopic Score for Crohn's Disease ( SES ‐ CD ) ≥ 7 Predicts Disease Progression
Alimentary Pharmacology & Therapeutics · 2025
DOI: 10.1111/apt.18492 ↗At a glance
Evaluationsstudie in Alimentary Pharmacology & Therapeutics, 2025. Written by Jellyana Peraza and 11 co-authors. Institution: The Dr. Henry D. Janowitz Division Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Major MEDLINE topics: Crohn Disease, Endoscopy, Gastrointestinal. Cited 6 times so far (Crossref); 28 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, NCATS NIH HHS.
Abstract (original language)
Background
Up to 30% of patients with Crohn's disease (CD) will experience a mild disease course. However, there is no consensus definition for mild CD.
Aim
To examine the Simple Endoscopic Score for Crohn's disease (SES‐CD) thresholds best associated with low likelihood of long‐term disease progression.
Methods
We conducted a multicentre retrospective cohort study at three tertiary care centres in United States and Europe. We analysed data from 177 surgery‐naïve patients with CD who had endoscopic assessment while not on immunosuppressive therapy. The primary outcome was disease progression (systemic steroids, biologic or immunomodulator therapy initiation; new stricturing or penetrating complications; or CD‐related hospitalisation or surgery). Univariable and multivariable Cox proportional hazards modelling identified predictors of the primary outcome at 2 and 5 years following endoscopy.
Results
Disease progression occurred in 23% and 35% of patients at years two and five, respectively. Endoscopic severity at enrolment independently predicted disease progression. Compared to those with an SES‐CD of 0, an SES‐CD ≥ 7 had a greater risk of progression at 2 years (HR 2.50, 95% CI 1.09–5.72) and 5 years (HR 2.89, 95% CI 1.41–5.91). SES‐CD > 7 remained independently predictive of disease progression among the 129 immunosuppression‐naïve patients (HR 5.65, 95% CI 1.49–21.52) and after excluding patients with prior penetrating disease (HR 2.32, 95% CI 1.00–5.45).
Conclusions
SES‐CD ≥ 7 predicts disease progression in mild CD. A score ≤ 6 may help identify patients less likely to progress and be part of the definition of mild CD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- The Dr. Henry D. Janowitz Division Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Division of Gastroenterology, Hospital Beatriz Angelo, Loures, Portugal.
- Center for Molecular Prediction of Inflammatory Bowel Disease, Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark.
- Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
- Division of Gastroenterology, Hospital da Luz, Lisbon, Portugal.
ORCID profiles: Jellyana Peraza, Manasi Agrawal, Lone Larsen, Henrik Albaek Jacobsen, Jean-Frederic Colombel, Joana Torres, Ryan C Ungaro, Ashwin N Ananthakrishnan
Funding
- NIDDK NIH HHS
- NCATS NIH HHS
Cite
APA
Peraza, J., Kaper, M. E., Bargas, A., Kim, I., Agrawal, M., Larsen, L., Jacobsen, H. A., Jess, T., Colombel, J. F., Torres, J., Ungaro, R. C., & Ananthakrishnan, A. N. (2025). A Simple Endoscopic Score for Crohn's Disease ( SES ‐ CD ) ≥ 7 Predicts Disease Progression. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18492
Vancouver
Peraza J, Kaper ME, Bargas A, Kim I, Agrawal M, Larsen L, et al. A Simple Endoscopic Score for Crohn's Disease ( SES ‐ CD ) ≥ 7 Predicts Disease Progression. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.18492
BibTeX
@article{Peraza2025,
author = {Peraza, Jellyana and Kaper, Marco Emilio and Bargas, Andre and Kim, Iris and Agrawal, Manasi and Larsen, Lone and Jacobsen, Henrik Albaek and Jess, Tine and Colombel, Jean-Frederic and Torres, Joana and Ungaro, Ryan C and Ananthakrishnan, Ashwin N},
title = {A Simple Endoscopic Score for Crohn's Disease ( SES ‐ CD ) ≥ 7 Predicts Disease Progression},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
doi = {10.1111/apt.18492}
}
EUVIMED